4//SEC Filing
Cundy Kenneth C 4
Accession 0001209191-22-061093
CIK 0001815974other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 9:19 PM ET
Size
8.5 KB
Accession
0001209191-22-061093
Insider Transaction Report
Form 4
Cundy Kenneth C
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2022-12-09+35,017→ 35,017 totalExercise: $3.37Exp: 2032-12-08→ Common Stock (35,017 underlying)
Footnotes (1)
- [F1]The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter first occurring after December 9, 2022.
Documents
Issuer
Anebulo Pharmaceuticals, Inc.
CIK 0001815974
Entity typeother
Related Parties
1- filerCIK 0001322959
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 9:19 PM ET
- Size
- 8.5 KB